SIE has interest portfolio of products and some with huge sale potential.
It will be interesting to see the income flow from the distribution agreement with a local China company for Insulin. If the information in the Distribution Agreement ( with the new Chinese distributor ) is correct, diabetes seems to he a significantly under treated disease is China and there is the potential for significant increase in the use of Insulin.
SIE Price at posting:
1.8¢ Sentiment: Hold Disclosure: Held
